A novel double-targeted nondrug delivery system for targeting cancer stem cells

References

• VisvaderJELindemanGJCancer stem cells in solid tumours: accumulating evidence and unresolved questionsNat Rev Cancer200881075576818784658
   PubMed Web of Science ®Google Scholar
• YanYZuoXWeiDConcise review: emerging role of CD44 in cancer stem cells: a promising biomarker and therapeutic targetStem Cells Transl Med2015491033104326136504
   PubMed Web of Science ®Google Scholar
• ChanmeeTOntongPKimataKItanoNKey roles of hyaluronan and its CD44 receptor in the stemness and survival of cancer stem cellsFront Oncol2015518026322272
   PubMed Web of Science ®Google Scholar
• JaggupilliAElkordESignificance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguityClin Dev Immunol2012201270803622693526
   PubMedGoogle Scholar
• PlaksVKongNWerbZThe cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?Cell Stem Cell201516322523825748930
   PubMed Web of Science ®Google Scholar
• MukherjeeNSchwanJVFujitaMNorrisDAShellmanYGAlternative treatments for melanoma: targeting BCL-2 family members to de-bulk and kill cancer stem cellsJ Invest Dermatol201513592155216125947358
   PubMedGoogle Scholar
• CioffiMTrabuloSHidalgoMInhibition of CD47 effectively targets pancreatic cancer stem cells via dual mechanismsClin Cancer Res201521102325233725717063
   PubMed Web of Science ®Google Scholar
• ConleySJGheordunescuEKakaralaPAntiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxiaProc Natl Acad Sci U S A201210982784278922308314
   PubMed Web of Science ®Google Scholar
• HirschHAIliopoulosDStruhlKMetformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growthProc Natl Acad Sci U S A2013110397297723277563
   PubMed Web of Science ®Google Scholar
• UiboRLaidmaeISawyerESSoft materials to treat central nervous system injuries: evaluation of the suitability of non-mammalian fibrin gelsBiochim Biophys Acta20091793592493019344675
   PubMed Web of Science ®Google Scholar
• ZuoZQChenKGYuXYPromoting tumor penetration of nanoparticles for cancer stem cell therapy by TGF-beta signaling pathway inhibitionBiomaterials201582485926751819
   PubMedGoogle Scholar
• HaraguchiNIshiiHMimoriKCD13 is a therapeutic target in human liver cancer stem cellsJ Clin Invest201012093326333920697159
   PubMed Web of Science ®Google Scholar
• KaluzovaMBourasAMachaidzeRHadjipanayisCGTargeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticlesOncotarget20156118788880625871395
   PubMedGoogle Scholar
• WangCHChiouSHChouCPChenYCHuangYJPengCAPhotothermolysis of glioblastoma stem-like cells targeted by carbon nanotubes conjugated with CD133 monoclonal antibodyNanomedicine201171697920620237
   PubMed Web of Science ®Google Scholar
• TanGRFengSSLeongDTThe reduction of anti-cancer drug antagonism by the spatial protection of drugs with PLA-TPGS nanoparticlesBiomaterials20143593044305124439415
   PubMedGoogle Scholar
• PrabhuRHPatravaleVBJoshiMDPolymeric nanoparticles for targeted treatment in oncology: current insightsInt J Nanomedicine2015101001101825678788
   PubMed Web of Science ®Google Scholar
• FangJNakamuraHMaedaHThe EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effectAdv Drug Deliv Rev201163313615120441782
   PubMed Web of Science ®Google Scholar
• YaoHJZhangYGSunLLiuYThe effect of hyaluronic acid functionalized carbon nanotubes loaded with salinomycin on gastric cancer stem cellsBiomaterials201435339208922325115788
   PubMed Web of Science ®Google Scholar
• WangDHuangJWangXThe eradication of breast cancer cells and stem cells by 8-hydroxyquinoline-loaded hyaluronan modified mesoporous silica nanoparticle-supported lipid bilayers containing docetaxelBiomaterials201334317662767323859657
   PubMed Web of Science ®Google Scholar
• HuKZhouHLiuYHyaluronic acid functional amphipathic and redox-responsive polymer particles for the co-delivery of doxorubicin and cyclopamine to eradicate breast cancer cells and cancer stem cellsNanoscale20157188607861825898852
   PubMed Web of Science ®Google Scholar
• WangHAgarwalPZhaoSHyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cellsBiomaterials201572748926344365
   PubMed Web of Science ®Google Scholar
• FlygareJAPillowTHAristoffPAntibody-drug conjugates for the treatment of cancerChem Biol Drug Des201381111312123253133
   PubMed Web of Science ®Google Scholar
• SharghVHHondermarckHLiangMAntibody-targeted biodegradable nanoparticles for cancer therapyNanomedicine (Lond)2016111637926654068
   PubMedGoogle Scholar
• WangCBaoCLiangSHAI-178 antibody-conjugated fluorescent magnetic nanoparticles for targeted imaging and simultaneous therapy of gastric cancerNanoscale Res Lett20149127424948895
   PubMedGoogle Scholar
• SwaminathanSKRogerETotiUNiuLOhlfestJRPanyamJCD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancerJ Control Release2013171328028723871962
   PubMed Web of Science ®Google Scholar
• LiLNeavesWBNormal stem cells and cancer stem cells: the niche mattersCancer Res20066694553455716651403
   PubMed Web of Science ®Google Scholar
• NakanishiYSenoHFukuokaADclk1 distinguishes between tumor and normal stem cells in the intestineNat Genet20134519810323202126
   PubMed Web of Science ®Google Scholar
• MetcalfeCde SauvageFJA tumor-specific stem cellNat Genet20134517923268130
   PubMedGoogle Scholar
• QiaoSPZhaoYFLiCFAn alginate-based platform for cancer stem cell researchActa Biomater201637839227109764
   PubMedGoogle Scholar
• LiuCWLinWJPolymeric nanoparticles conjugate a novel heptapeptide as an epidermal growth factor receptor-active targeting ligand for doxorubicinInt J Nanomedicine201274749476722973097
   PubMed Web of Science ®Google Scholar
• YoonJJNamYSKimJHParkTGSurface immobilization of galactose onto aliphatic biodegradable polymers for hepatocyte cultureBiotechnol Bioeng200278111011857274
   PubMedGoogle Scholar
• SenthilkumarMMishraPJainNKLong circulating PEGylated poly(D,L-lactide-co-glycolide) nanoparticulate delivery of Docetaxel to solid tumorsJ Drug Target200816542443518569287
   PubMed Web of Science ®Google Scholar
• Abdel-LatifAZuba-SurmaEKCaseJTGF-beta1 enhances cardiomyogenic differentiation of skeletal muscle-derived adult primitive cellsBasic Res Cardiol2008103651452418500484
   PubMedGoogle Scholar
• FangRQiaoSLiuYSustained co-delivery of BIO and IGF-1 by a novel hybrid hydrogel system to stimulate endogenous cardiac repair in myocardial infarcted rat heartsInt J Nanomedicine2015104691470326251592
   PubMed Web of Science ®Google Scholar
• Gutiérrez-PraenaDPichardoSSánchezEGriloACameánAMJosAInfluence of carboxylic acid functionalization on the cytotoxic effects induced by single wall carbon nanotubes on human endothelial cells (HUVEC)Toxicol In Vitro20112581883188821651974
   PubMed Web of Science ®Google Scholar
• AlisonMRLinWRLimSMNicholsonLJCancer stem cells: in the line of fireCancer Treat Rev201238658959822469558
   PubMed Web of Science ®Google Scholar
• AlisonMRLimSMNicholsonLJCancer stem cells: problems for therapy?J Pathol2011223214716121125672
   PubMed Web of Science ®Google Scholar
• MalhiSGuXNanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approachExpert Opin Drug Deliv20151271177120125601619
   PubMed Web of Science ®Google Scholar
• ShenSXiaJXWangJNanomedicine-mediated cancer stem cell therapyBiomaterials20167411826433488
   PubMed Web of Science ®Google Scholar
• ChaudhuriOKoshySTBrancoDCCExtracellular matrix stiffness and composition jointly regulate the induction of malignant phenotypes in mammary epitheliumNat Mater2014131097097824930031
   PubMed Web of Science ®Google Scholar
• HanJChenLLuoGDaiBWangXDaiJThree-dimensional culture may promote cell reprogrammingOrganogenesis20139211812023820263
   PubMed Web of Science ®Google Scholar
• HiragaTItoSNakamuraHEpCAM expression in breast cancer cells is associated with enhanced bone metastasis formationInt J Cancer201613871698170826576938
   PubMedGoogle Scholar
• YangXSarvestaniSKMoeinzadehSHeXJabbariEThree-dimensional-engineered matrix to study cancer stem cells and tumorsphere formation: effect of matrix modulusTissue Eng Part A2013195–666968423013450
   PubMedGoogle Scholar
• WeygantNQuDMayRDCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinomaOncotarget2015642193220525605241
   PubMedGoogle Scholar
• SurebanSMQuDHouchenCWRegulation of miRNAs by agents targeting the tumor stem cell markers DCLK1, MSI1, LGR5, and BMI1Curr Pharmacol Rep20151421722226366338
   PubMedGoogle Scholar
• LiYPeiYZhangXPEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in ratsJ Control Release200171220321111274752
   PubMed Web of Science ®Google Scholar
• DanhierFAnsorenaESilvaJMCocoRLe BretonAPréatVPLGA-based nanoparticles: an overview of biomedical applicationsJ Control Release2012161250552222353619
   PubMed Web of Science ®Google Scholar
• ZhongYZhangJChengRReversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenograftsJ Control Release201520514415425596560
   PubMed Web of Science ®Google Scholar
• ZollerMCD44: can a cancer-initiating cell profit from an abundantly expressed molecule?Nat Rev Cancer201111425426721390059
   PubMed Web of Science ®Google Scholar
• NiMXiongMZhangXPoly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cellsInt J Nanomedicine2015102537255425848270
   PubMed Web of Science ®Google Scholar
• XieXLiFZhangHEpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug deliveryEur J Pharm Sci201583283526690044
   PubMedGoogle Scholar